3229-1793 Screening compound: (5E)-5-[(3-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione

3229-1793 Screening compound: (5E)-5-[(3-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione
3229-1793 Screening compound: (5E)-5-[(3-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound 3229-1793
(5E)-5-[(3-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3229-1793

Molecular Formula

C11H9NO3S (C11 H9 NO3 S)

Compound Name

(5E)-5-[(3-methoxyphenyl)methylidene]-1,3-thiazolidine-2,4-dione

IUPAC name

(5E)-5-[(3-methoxyphenyl)methylidene]-13-thiazolidine-24-dione

SMILES

COc1cccc(/C=C(\C(N2)=O)/SC2=O)c1

InChI

InChI=1S/C11H9NO3S/c1-15-8-4-2-3-7(5-8)6-9-10(13)12-11(14)16-9/h2-6H,1H3,(H,12,13,14)

InChI Key

IPQWMGNQGDHUJR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00640644

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

235.26

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

1.485

Distribution Coefficient, logD

1.450

Water Solubility, LogSw

-2.24

Polar Surface Area

45.452

Acid Dissociation Constant (pKa)

8.49

Base Dissociation Constant (pKb)

-2.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

3229-1793 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

Human Kinases Annotated Library (2415 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 3229-1793 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3229-1793?
Check Price and Availability of 3229-1793, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3229-1793 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3229-1793
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3229-1793
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3229-1793 available by request